Home

entlassen Wal Traurig behavioral and physiological effetc of novel kappa opioid receptor based dreadd Hand voll Tiefe Taube

PDF] Clozapine N-Oxide Administration Produces Behavioral Effects in  Long–Evans Rats: Implications for Designing DREADD Experiments | Semantic  Scholar
PDF] Clozapine N-Oxide Administration Produces Behavioral Effects in Long–Evans Rats: Implications for Designing DREADD Experiments | Semantic Scholar

Brain Sciences | Free Full-Text | Delta Opioid Receptors and  Enkephalinergic Signaling within Locus Coeruleus Promote Stress Resilience
Brain Sciences | Free Full-Text | Delta Opioid Receptors and Enkephalinergic Signaling within Locus Coeruleus Promote Stress Resilience

The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to  clozapine and produces clozapine-like interoceptive stimulus effects in  rats and mice | Scientific Reports
The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice | Scientific Reports

The claustrum-prelimbic cortex circuit through dynorphin/κ-opioid receptor  signaling underlies depression-like behaviors associated with social stress  etiology | Nature Communications
The claustrum-prelimbic cortex circuit through dynorphin/κ-opioid receptor signaling underlies depression-like behaviors associated with social stress etiology | Nature Communications

Ligand and G-protein selectivity in the κ-opioid receptor | Nature
Ligand and G-protein selectivity in the κ-opioid receptor | Nature

Behavioral and Physiological Effects of a Novel Kappa-Opioid Receptor-Based  DREADD in Rats | Neuropsychopharmacology
Behavioral and Physiological Effects of a Novel Kappa-Opioid Receptor-Based DREADD in Rats | Neuropsychopharmacology

Frontiers | Dynorphin/kappa opioid receptor system regulation on amygdaloid  circuitry: Implications for neuropsychiatric disorders
Frontiers | Dynorphin/kappa opioid receptor system regulation on amygdaloid circuitry: Implications for neuropsychiatric disorders

Dynorphin / kappa-opioid receptor regulation of excitation-inhibition  balance toggles afferent control of prefrontal cortical circuits in a  pathway-specific manner | Molecular Psychiatry
Dynorphin / kappa-opioid receptor regulation of excitation-inhibition balance toggles afferent control of prefrontal cortical circuits in a pathway-specific manner | Molecular Psychiatry

A Cre Driver Line for Genetic Targeting of Kappa Opioid Receptor Expressing  Cells | eNeuro
A Cre Driver Line for Genetic Targeting of Kappa Opioid Receptor Expressing Cells | eNeuro

Kappa-opioid receptor stimulation in the nucleus accumbens shell:  Differential effects across the rostro-caudal axis on dopamine transmission  and affective behavior | bioRxiv
Kappa-opioid receptor stimulation in the nucleus accumbens shell: Differential effects across the rostro-caudal axis on dopamine transmission and affective behavior | bioRxiv

Opioid receptors: drivers to addiction? | Nature Reviews Neuroscience
Opioid receptors: drivers to addiction? | Nature Reviews Neuroscience

Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or  approach-avoidance behavior occur differentially across the nucleus  accumbens shell rostro-caudal axis - ScienceDirect
Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis - ScienceDirect

Frontiers | Traumatic Stress-Induced Vulnerability to Addiction: Critical  Role of the Dynorphin/Kappa Opioid Receptor System
Frontiers | Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System

New Technologies for Elucidating Opioid Receptor Function: Trends in  Pharmacological Sciences
New Technologies for Elucidating Opioid Receptor Function: Trends in Pharmacological Sciences

Frontiers | Dynorphin/kappa opioid receptor system regulation on amygdaloid  circuitry: Implications for neuropsychiatric disorders
Frontiers | Dynorphin/kappa opioid receptor system regulation on amygdaloid circuitry: Implications for neuropsychiatric disorders

A Cre Driver Line for Genetic Targeting of Kappa Opioid Receptor Expressing  Cells | eNeuro
A Cre Driver Line for Genetic Targeting of Kappa Opioid Receptor Expressing Cells | eNeuro

Resolving Behavioral Output via Chemogenetic Designer Receptors Exclusively  Activated by Designer Drugs | Journal of Neuroscience
Resolving Behavioral Output via Chemogenetic Designer Receptors Exclusively Activated by Designer Drugs | Journal of Neuroscience

Chemogenetics drives paradigm change in the investigation of behavioral  circuits and neural mechanisms underlying drug action - ScienceDirect
Chemogenetics drives paradigm change in the investigation of behavioral circuits and neural mechanisms underlying drug action - ScienceDirect

Behavioral and Physiological Effects of a Novel Kappa-Opioid Receptor-Based  DREADD in Rats | Neuropsychopharmacology
Behavioral and Physiological Effects of a Novel Kappa-Opioid Receptor-Based DREADD in Rats | Neuropsychopharmacology

Clozapine N-Oxide Administration Produces Behavioral Effects in Long–Evans  Rats: Implications for Designing DREADD Experiments | eNeuro
Clozapine N-Oxide Administration Produces Behavioral Effects in Long–Evans Rats: Implications for Designing DREADD Experiments | eNeuro

Frontiers | The Use of DREADDs to Deconstruct Behavior
Frontiers | The Use of DREADDs to Deconstruct Behavior

An Overview of Chemogenetics
An Overview of Chemogenetics

Modulating Dopamine Signaling and Behavior with Chemogenetics: Concepts,  Progress, and Challenges | Pharmacological Reviews
Modulating Dopamine Signaling and Behavior with Chemogenetics: Concepts, Progress, and Challenges | Pharmacological Reviews